Try our beta test site

Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
University of Florida
ClinicalTrials.gov Identifier:
NCT01987193
First received: October 24, 2013
Last updated: October 3, 2016
Last verified: October 2016
  Purpose
The purpose of this study is the development of noninvasive (having no direct contact) detector and electronic system that will directly measure tumor blood flow rate.

Condition
Brain Cancer
Prostate Cancer
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy

Resource links provided by NLM:


Further study details as provided by University of Florida:

Primary Outcome Measures:
  • Patients with hypoxic tumor identified by tumor blood flow measurement. [ Time Frame: 3 months ]

Estimated Enrollment: 10
Study Start Date: July 2012
Estimated Study Completion Date: June 2019
Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients treated at radiation oncology clinic
Criteria

Inclusion Criteria:

Solid tumors in the intracranial, thoracic, or pelvic regions.

Exclusion Criteria: N/A

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01987193

Locations
United States, Florida
University of Florida Proton Therapy Institute
Jacksonville, Florida, United States, 32206
Sponsors and Collaborators
University of Florida
Investigators
Principal Investigator: Zhong Su, PhD University of Florida Proton Therapy Institute
  More Information

Responsible Party: University of Florida
ClinicalTrials.gov Identifier: NCT01987193     History of Changes
Other Study ID Numbers: UFPTI 1214 - DS01
Study First Received: October 24, 2013
Last Updated: October 3, 2016
Individual Participant Data  
Plan to Share IPD: Undecided

Keywords provided by University of Florida:
Proton radiation
tumor blood flow

Additional relevant MeSH terms:
Brain Neoplasms
Central Nervous System Neoplasms
Nervous System Neoplasms
Neoplasms by Site
Neoplasms
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on March 24, 2017